newsfilter
← Latest News
GlobeNewswire·

Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026

New Clinical Studies Validate BVA™ Technology in High-Acuity Heart Failure Populations to Enhance Care OAK RIDGE, TN, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood